They were also used in phase I for the intracerebral delivery of nerve growth factor in Alzheimer’s disease and modified for the delivery of glial cell line-derived neurotrophic factor in Parkinson’s disease.56 The gene discussed is GDNF; the disease is Parkinson disease.